JESSIE BLACK: Open Payments
NPI 1740903681 · CHICKASAW, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$241 in 8 payments from 7 companies in 2025. Trend: 2023 $509 · 2024 $126 · 2025 $241
Food & beverage: $241
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 2 | $141 |
| Mozarc Medical US LLC | 1 | $23 |
| Apellis Pharmaceuticals, Inc. | 1 | $17 |
| Amgen Inc. | 1 | $16 |
| Alexion Pharmaceuticals, Inc. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: TARPEYO, PALINDROME, Empaveli, KRYSTEXXA, ULTOMIRIS, JYNARQUE, FARXIGA.
Industry payments across AL — which companies pay providers there.
